Human PD-L1/B7-H1 Protein
Catalog No: PDL1-HP009
- Species
- Human
- Expression System
- HEK293
- Tag
- Llama Fc
- Activity
- Activity verified
Product overview
Recombinant Human PD-L1/B7-H1 Protein is expressed in HEK293 cells with Llama Fc tag at the C-terminus. It contains amino acid residues Phe19-Arg238 (UniProt accession: Q9NZQ7-1).
Product Details
- Molecular Aliases
- CD274; PDL1; PD-L1; PD-L1B7 homolog 1;B7-H; B7H1; B7-H1; PDCD1L1; PDCD1LG1
- Protein Length
- Phe19-Arg238
- Expression System
- HEK293
- Theoretical Molecular Weight
- The protein has a predicted MW of 52.50 kDa. Due to glycosylation, the protein migrates to 65-75 kDa based on Bis-Tris PAGE result.
- Purity
- > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
- Endotoxin
- Less than 1 EU per μg by the LAL method.
- Buffer / Formulation
- Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
- State
- Lyophilized
- Storage Conditions
- -20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Reconstitution Advice
- Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.
Data Display
Human PD-L1 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Human PD-L1 is greater than 95% as determined by SEC-HPLC.
Immobilized Human PD-L1, LIama Fc Tag at 5μg/ml (100μl/well) on the plate. Dose response curve for Human PD-1, mFc Tag with the EC50 of 0.17μg/ml determined by ELISA.
Background
B7-H1, also known as PD-L1 and CD274, is an approximately 65 kDa transmembrane glycoprotein in the B7 family of immune regulatory molecules. PD-L1 has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance.
References
- Blank C, Mackensen A. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion[J]. Cancer Immunology Immunotherapy, 2007, 56(5):739-745. Note: HPLC results always come from liquid protein, due to absorption peak interference of trehalose in lyophilized powder.
Have questions about this product?
Our technical team can help with product selection, application questions and order support.